Similar articles

Abstract: long non-coding RNAs (lncRNAs) play a significant role in maintaining tissue morphology and functions, and their precise regulatory effectiveness is closely related to expression patterns. However, the spatial expression patterns of lncRNAs in humans are poorly characterized. Here, we constructed five comprehensive transcriptomic atlases of human lncRNAs covering thousands of major tissue samples in normal and disease states. The lncRNA transcriptomes exhibited high consistency within the same tissues across resources, and even higher complexity in specialized tissues. Tissue-elevated (TE) lncRNAs were identified in each resource and robust TE lncRNAs were refined by integrative analysis. We detected 1 to 4684 robust TE lncRNAs across tissues; the highest number was in testis tissue, followed by brain tissue. Functional analyses of TE lncRNAs indicated important roles in corresponding tissue-related pathways. Moreover, we found that the expression features of robust TE lncRNAs made them be effective biomarkers to distinguish tissues; TE lncRNAs also tended to be associated with cancer, and exhibited differential expression or were correlated with patient survival. In summary, spatial classification of lncRNAs is the starting point for elucidating the function of lncRNAs in both maintenance of tissue morphology and progress of tissue-constricted diseases.

长链非编码RNA空间转录组分析揭示组织特异性和癌症中的功能

[1]AkenBL, AchuthanP, AkanniW, et al., 2017. Ensembl 2017. Nucleic Acids Res, 45(D1):D635-D642.

[2]AranD, CamardaR, OdegaardJ, et al., 2017. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun, 8:1077.

[3]BurgessDJ, 2015. Spatial characterization of proteomes. Nat Rev Genet, 16(3):129.

[4]CabiliMN, TrapnellC, GoffL, et al., 2011. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev, 25(18):1915-1927.

[5]ChenG, WangZY, WangDQ, et al., 2013. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res, 41(D1):D983-D986.

[6]ChenHY, SunJ, HeYQ, et al., 2015. Expression and localization of testis developmental related gene 1 (TDRG1) in human spermatozoa. Tohoku J Exp Med, 235(2):‍103-109.

[7]ColapricoA, SilvaTC, OlsenC, et al., 2016. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res, 44(8):e71.

[8]CreaF, WatahikiA, QuagliataL, et al., 2014. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget, 5(3):764-774.

[9]DanielssonF, JamesT, Gomez-CabreroD, et al., 2015. Assessing the consistency of public human tissue RNA-seq data sets. Brief Bioinform, 16(6):941-949.

[10]DerasIL, AubinSMJ, BlaseA, et al., 2008. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol, 179(4):1587-1592.

[11]DerrienT, JohnsonR, BussottiG, et al., 2012. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res, 22(9):1775-1789.

[12]DuZ, FeiT, VerhaakRGW, et al., 2013. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol, 20(7):908-913.

[13]EisenbergE, LevanonEY, 2013. Human housekeeping genes, revisited. Trends Genet, 29(10):569-574.

[14]FuPF, ZhengX, FanX, et al., 2019. Role of cytoplasmic lncRNAs in regulating cancer signaling pathways. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(1):1-8.

[15]GanY, WangY, TanZY, et al., 2016. TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway. Cancer Biol Ther, 17(7):741-750.

[16]GaoY, WangP, WangYX, et al., 2019. Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers. Nucleic Acids Res, 47(D1):D1028-D1033.

[17]GuoYB, LiuYY, WangH, et al., 2021. Long noncoding RNA SRY-box transcription factor 2 overlapping transcript participates in Parkinson’s disease by regulating the microRNA-942-5p/nuclear apoptosis-inducing factor 1 axis. Bioengineered, 12(1):8570-8582.

[18]GuptaRA, ShahN, WangKC, et al., 2010. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464(7291):1071-1076.

[19]HonCC, RamilowskiJA, HarshbargerJ, et al., 2017. An atlas of human long non-coding RNAs with accurate 5' ends. Nature, 543(7644):199-204.

[20]HungT, WangYL, LinMF, et al., 2011. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet, 43(7):621-629.

[21]JiangXZ, LiDJ, YangJF, et al., 2011. Characterization of a novel human testis-specific gene: testis developmental related gene 1 (TDRG1). Tohoku J Exp Med, 225(4):‍‍311-318.

[22]JongeneelCV, DelorenziM, IseliC, et al., 2005. An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res, 15(7):1007-1014.

[23]KimD, PerteaG, TrapnellC, et al., 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol, 14(4):R36.

[24]KlijnC, DurinckS, StawiskiEW, et al., 2015. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol, 33(3):306-312.

[25]LiL, EichtenSR, ShimizuR, et al., 2014. Genome-wide discovery and characterization of maize long non-coding RNAs. Genome Biol, 15(2):R40.

[26]LiSL, LiYC, ChenB, et al., 2018. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res, 46(D1):D106-D112.

[27]LiYS, LiLL, WangZS, et al., 2018. LncMAP: pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations. Nucleic Acids Res, 46(3):1113-1123.

[28]LiYS, JiangTTF, ZhouWW, et al., 2020. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun, 11:1000.

[29]LingadahalliS, JadhaoS, SungYY, et al., 2018. Novel lncRNA LINC00844 regulates prostate cancer cell migration and invasion through AR signaling. Mol Cancer Res, 16(12):1865-1878.

[30]LonsdaleJ, ThomasJ, SalvatoreM, et al., 2013. The Genotype-Tissue Expression (GTEx) project. Nat Genet, 45(6):‍580-585.

[31]LvDZ, XuK, JinXY, et al., 2020. LncSpA: lncRNA spatial atlas of expression across normal and cancer tissues. Cancer Res, 80(10):2067-2071.

[32]MerolaR, TomaoL, AntenucciA, et al., 2015. PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience. J Exp Clin Cancer Res, 34:15.

[33]NewmanAM, LiuCL, GreenMR, et al., 2015. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods, 12(5):453-457.

[34]NoguchiS, ArakawaT, FukudaS, et al., 2017. FANTOM5 CAGE profiles of human and mouse samples. Sci Data, 4:170112.

[35]PanzittK, TschernatschMMO, GuellyC, et al., 2007. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 132(1):330-342.

[36]QuL, HeXY, TangQ, et al., 2022. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(10):844-862.

[37]RamsköldD, WangET, BurgeCB, et al., 2009. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol, 5(12):e1000598.

[38]RawalHC, AngadiU, MondalTK, 2021. TEnGExA: an R package based tool for tissue enrichment and gene expression analysis. Brief Bioinform, 22(3):bbaa221.

[39]RenSC, WangFB, ShenJ, et al., 2013. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer, 49(13):2949-2959.

[40]RusticiG, KolesnikovN, BrandiziM, et al., 2013. ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res, 41(D1):D987-D990.

[41]SalemM, PaneruB, Al-TobaseiR, et al., 2015. Transcriptome assembly, gene annotation and tissue gene expression atlas of the rainbow trout. PLoS ONE, 10(3):e0121778.

[42]SchrothG, 2011. RNA-Seq of human individual tissues and mixture of 16 tissues (Illumina Body Map). BioStudies, E-MTAB-513. Retrieved from https://www.ebi.‍ac.‍uk/biostudies/arrayexpress/studies/E-MTAB-513

[43]SheXW, RohlCA, CastleJC, et al., 2009. Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics, 10:269.

[44]The Cancer Genome Atlas Research Network, WeinsteinJN, CollissonEA, et al., 2013. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet, 45(10):1113-1120.

[45]TrapnellC, RobertsA, GoffL, et al., 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc, 7(3):562-578.

[46]UhlenM, OksvoldP, FagerbergL, et al., 2010. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol, 28(12):1248-1250.

[47]UhlénM, FagerbergL, HallströmBM, et al., 2015. Tissue-based map of the human proteome. Science, 347(6220):1260419.

[48]UhlénM, HallströmBM, LindskogC, et al., 2016. Transcriptomics resources of human tissues and organs. Mol Syst Biol, 12(4):862.

[49]WangDX, EraslanB, WielandT, et al., 2019. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol Syst Biol, 15(2):e8503.

[50]WangY, GanY, TanZ, et al., 2016. TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway. OncoTargets Ther, 9:409-420.

[51]WeiJC, GanY, PengDY, et al., 2018. Long non-coding RNA H19 promotes TDRG1 expression and cisplatin resistance by sequestering miRNA-106b-5p in seminoma. Cancer Med, 7(12):6247-6257.

[52]XuJ, ShaoTT, SongMX, et al., 2020. MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer. Mol Cancer, 19:‍51.

[53]YuNYL, HallströmBM, FagerbergL, et al., 2015. Complementing tissue characterization by integrating transcriptome profiling from the Human Protein Atlas and from the FANTOM5 consortium. Nucleic Acids Res, 43(14):6787-6798.

[54]ZhouCC, YangF, YuanSX, et al., 2016. Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma. Hepatology, 63(3):850-863.

[55]ZhuJH, ChenG, ZhuSB, et al., 2016. Identification of tissue-specific protein-coding and noncoding transcripts across 14 human tissues using RNA-seq. Sci Rep, 6:28400.